Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Merck invests EUR 7.6 million

Two billion tablets

“This comprises the largest single investment in the history of Merck Spittal“, says Klaus Raunegger, Managing Director of Merck in Spittal. The site has long become a showcase plant within the Merck Group of Germany. Four of the company’s eight most important brands on the global market are manufactured in Carinthia. “Over the last ten years the number of packs of medicine produced here has increased five-fold, from 14 million to 70 million. The volume of tablets manufactured in Spittal has climbed from 400 million to 1.3 billion”, Raunegger explains.  More than 90 percent of the medication is destined for export. In 2018, the “competence center” in Spittal is expected to manufacture about two billion tablets annually. The plant produces, amongst other products, various over the counter vitamin products and food supplements, nose sprays (Nasivin) and pain relief creams. The production of “Vigantoletten” (Vitamin D) is being transferred from Darmstadt to Spittal within the context of the expansion program.  Quality control also takes place at the Carinthian facility. Production volume has risen four-fold overall during the last ten years. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Expand to Austria

    26.06.2019, Brescia, Italy

  • Research Dialogue with Summery Jazz Sounds

    02.07.2019, Stuttgart, Germany

Austria Map

Find the perfect location for your company

One of Austria's key strengths as a business destination is its highly qualified and motivated skilled workforce for research and development, especially in the scientific sector.

Nestlé Austria

Logo
More testimonials

news from the business location Austria

Ottobock invests EUR 2 million in Vienna

The underlying basis of success of the globally recognised development work of the German life sciences company Ottobock being carried out in Vienna is the extremely pronounced medical research landscape offering fertile ground for interdisciplinary R&D projects.

Innovations from Austria for the Logistics Sector

At the present time there are many influencing factors which pose challenges to the supply chain and logistics management. Solutions in this area are frequently developed by startups, also from Austria. Several of them will present their innovations at the Austrian Logistics Day and Logistics Future Lab.

More news All blog posts